NCT05289687 2026-04-03Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALLEastern Cooperative Oncology GroupPhase 2 Recruiting20 enrolled
NCT03504644 2026-04-02Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic LeukemiaEastern Cooperative Oncology GroupPhase 1/2 Active not recruiting40 enrolled 18 charts